Jove
Visualize
Contact Us

Related Experiment Videos

Pneumococcal vaccine.

F M LaForce1

  • 1Department of Medicine, Genesee Hospital, Rochester, NY 14607.

Seminars in Respiratory Infections
|December 1, 1989
PubMed
Summary
This summary is machine-generated.

Pneumococcal infections pose a significant public health risk. This study indicates that pneumococcal vaccines are effective in patients likely to respond and at high risk for infection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[From genomics to surveillance, prevention and control: new challenges for the African meningitis belt].

Bulletin de la Societe de pathologie exotique (1990)·2007
Same author

Meningococcal meningitis.

Nature reviews. Microbiology·2005
Same author

Diagnosis of Jamestown Canyon encephalitis by polymerase chain reaction.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1999
Same author

"McFlu". The Monroe County, New York, Medicare vaccine demonstration.

American journal of preventive medicine·1999
Same author

Performance-based physician reimbursement and influenza immunization rates in the elderly. The Primary-Care Physicians of Monroe County.

American journal of preventive medicine·1998
Same author

Triaging care for patients with pneumonia. Real progress.

Archives of internal medicine·1997
Same journal

TB vaccines at the turn of the century: insights into immunity to M. tuberculosis and modern approaches for prevention of an ancient disease.

Seminars in respiratory infections·2003
Same journal

Environmental infection control of tuberculosis.

Seminars in respiratory infections·2003
Same journal

Mycobacterium tuberculosis: the treatment of active disease.

Seminars in respiratory infections·2003
Same journal

Pediatric tuberculosis.

Seminars in respiratory infections·2003
Same journal

Clinical and radiographic features of HIV-related tuberculosis.

Seminars in respiratory infections·2003
Same journal

Treatment of latent tuberculosis infection.

Seminars in respiratory infections·2003
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Infectious Diseases
  • Vaccinology
  • Public Health

Background:

  • Pneumococcal infections are a major public health concern.
  • Controversy exists regarding the effectiveness of pneumococcal vaccines in US populations.
  • Previous studies yielded conflicting results on vaccine efficacy.

Purpose of the Study:

  • To evaluate the effectiveness of a multivalent pneumococcal vaccine.
  • To address the controversy surrounding vaccine efficacy in specific populations.
  • To determine optimal conditions for pneumococcal vaccine effectiveness.

Main Methods:

  • Conducted two large case-control studies in Pennsylvania and Connecticut hospitals.
  • Matched patients with pneumococcal bacteremia to controls based on age and disease severity.

Related Experiment Videos

  • Excluded bacteremic immunosuppressed patients unlikely to respond to the vaccine.
  • Analyzed data from a prospective randomized controlled French trial using pneumonia episodes as an endpoint.

    • Main Results:

    • Case-control studies showed pneumococcal vaccine efficacy rates between 60% and 70%.
    • A French trial using pneumonia as an endpoint also indicated significant vaccine efficacy.
    • Exclusion of non-responsive groups improved observed efficacy rates.

    Conclusions:

    • Pneumococcal vaccine demonstrates effectiveness in populations likely to mount an immune response.
    • The vaccine is particularly effective in individuals at increased risk of pneumococcal infection.
    • Targeted vaccination strategies can enhance the public health impact of pneumococcal vaccines.